Nalmefene
Back to searchMolecule Structure
Scientific Name
Nalmefene
Description of the Drug
Nalmefene is an opioid antagonist used to reduce alcohol consumption in adults with alcohol dependence and treat and prevent opioid overdose.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06230
http://www.drugbank.ca/drugs/DB06230
Brand Name(s)
Selincro
Company Owner(s)
Hikma Pharmaceuticals Usa Inc, Purdue Pharma Lp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Opioid receptors; mu/kappa/delta | PROTEIN FAMILY | ANTAGONIST | CHEMBL2095181 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL35230 | |
DrugBank | DB06230 | |
PubChem: Thomson Pharma | 14875634 | 14753624 |
PubChem | 5284594 | |
LINCS | LSM-6644 | |
Nikkaji | J23.288B | |
BindingDB | 50045776 | |
EPA CompTox Dashboard | DTXSID8023347 | |
DrugCentral | 1876 | |
Metabolights | MTBLC7457 | |
Guide to Pharmacology | 1628 | |
rxnorm | NALMEFENE HYDROCHLORIDE | NALMEFENE |
PubChem: Drugs of the Future | 12013834 | |
KEGG Ligand | C08027 | |
ChEBI | 7457 | |
ZINC | ZINC000000403529 |